TQ Course | State of the Art Cataract Care (Nashville 2021) by Optometric Education Consultants | Nov 22, 2021 | 2021 Nashville, TQ Courses | 0 comments HiddenState of the Art Cataract CareHiddenDate (Hidden) MM slash DD slash YYYY 1. Which of the following is the most important determinant as to when a cataract is considered visually significant?* a. A moderately dense posterior subcapsular cataract b. A symptomatic patient whose quality of life has been impaired c. Best corrected visual acuity of 20/50 or worse d. Glare acuity worse than 20/400 2. All of the following are important preoperative optical considerations in the cataract surgery patient except:* a. Amplitude of accommodation b. Astigmatism c. Anisometropia d. Target refractive endpoint 3. 1. Which is NOT one known benefit of femtosecond technology?* a. Reproducible accuracy of every step b. Better outcomes c. A value proposition for patients d. An opportunity to optimize refractive cataract surgery 4. The Vivity IOL should be considered for patients with ALL of these patient characteristics EXCEPT for ONE?* a. Desires distance and intermediate b. Desires to not wear readers 100 percent of the time c. Desires no or decreased halos d. Is motivated to decrease the need for spectacle’s or contact lenses 5. A misalignment of a toric IOL by 15 degrees amounts to how many diopters of residual astigmatism?* a. 0.25 D b. 0 D c. 0.51 D d. 1.00 D 6. When comparing intracameral versus topical antibiotic prophylaxis in cataract surgery, which adverse event is more common with intracameral prophylaxis according to Herrinto et al.* a. Retinal detachment b. Cystoid macular edema c. Diabetic retinopathy d. None of the above 7. The patient can expect these two common findings after intracameral antibiotic prophylaxis.* a. Pain and irritation at the injection site b. Blurry vision for the first 48 hours and an increase in vitreous floaters c. Discharge from the injection site d. None of the above 8. In regards to premium IOL’s, what characteristics are critical to make them successful for patients.* a. Educating that it may take time to adapt b. Motivation and a belief by the patient and doctor in premium IOLs c. Supporting the patient in setting realistic expectations, encouragement and reassurance d. All of the above 9. What makes the Light Adjustable Lens unique?* a. Silicone Matrix b. The technique used to insert it into the capsular bag c. Photosensitive macromers d. It is capable of multifocality 10. Each of the following should be considered an early emergent postoperative complication except:* a. Cystoid macular edema (CME) b. Ocular hypotony with flat anterior chamber c. Severely elevated IOP d. Endophthalmitis 11. Each of the following statements are false except:* a. Ocular hypotony is most accurately determined by air puff tonometry b. Ocular hypotony secondary to ciliary body shutdown is more common than ocular hypotony secondary to wound leak c. Ocular hypotony with choroidal detachment requires an immediate referral to a retinal specialist d. Seidel testing is useful in differentiating wound leak from ciliary body shutdown and should be done when IOP following cataract surgery measures less than 6 mm Hg 12. Each of the following should be considered an early urgent postoperative complication except:* a. Hyphema b. Wound leak with well-formed anterior chamber c. Corneal edema d. IOL decentration 13. Each of the following statements are true except:* a. Posterior synechiae, anticoagulants, and iris neovascularization are risk factors for surgical hyphema b. Aspirin, Coumadin, and Flomax are all examples of medicines predisposing to surgical hyphema c. Maintaining anticoagulants prior to surgery may be supported from a risk-benefit standpoint d. Surgical hyphemas typically resolve quicker than traumatic hyphemas 14. Each of the following are indications for IOL repositioning or exchange of a malpositioned IOL except:* a. Diplopia b. Uveitis-Glaucoma-Hyphema (UGH) syndrome c. Significant visual acuity change d. Chronic pupil capture of IOL 15. Management of a wound leak following cataract surgery the previous day may include all of the following except:* a. Increasing the topical corticosteroid b. Continuing a broad spectrum topical antibiotic c. Considering an eye shield be worn at bedtime d. Suturing of wound if not resolved within one week 16. Intermediate to late postoperative complications include all of the following except:* a. Pseudophakic cystoid macular edema (CME) b. Persistent iritis c. Ocular hypotony d. Glaucoma 17. Clinical detection of macular edema includes all of the following except:* a. Careful biomicroscopic evaluation of the macula with a high plus fundus lens, looking for elevation and cysts b. Careful slitlamp examination of the anterior chamber, looking for low grade cells and flare c. Careful measurement of potential (retinal) acuity with comparison to preoperative measurement d. Careful intraocular pressure measurement by tonometry 18. A cataract surgery patient, at the 1-day followup, presents with slightly blurred vision and mild ocular discomfort, Goldmann applanation IOP = 3, a negative Seidel test, and a mild conjunctival bleb formation at the wound site. Likely diagnosis is:* a. Endophthalmitis b. Wound leak c. Ciliary body shutdown d. Choroidal detachment 19. A cataract surgery patient, at the 1-day followup, is diagnosed with hyphema, both circulating microhyphema and layered hyphema, and has hand motion vision. Management should include all of the following except:* a. Increase the topical corticosteroid frequency b. Avoid applanation tonometry until hyphema clears c. Avoid vigorous activities and unprescribed anticoagulants d. Compassionate reassurance and followup in 3-5 days 20. A patient having had uncomplicated cataract surgery two months ago presents with clinical findings consistent with pseudophakic CME and a best corrected visual acuity of 20/50 in the operated eye and 20/20 in the fellow eye. The most suitable initial treatment option is:* a. TobraDex 1 drop qid with reevaluation in 2 weeks b. Intravitreal Kenalog injection with reevaluation in 1 week c. Periocular Kenalog injection with reevaluation in 1 week d. Pred Forte and a topical NSAID each 1 drop qid with reevaluation in 3 weeks Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongo, Democratic Republic of theCongo, Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatini (Swaziland)EthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth GeorgiaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaVietnamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code State of the Art Cataract Care | TQ Credit*After 1/19/2022, pricing will increase to $30. Price: (Past 60 Days) State of the Art Cataract Care | TQ CreditThis course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: (Past 60 Days) Retake Discount Price: Payment MethodPayPal Checkout MasterCardVisaSupported Credit Cards: MasterCard, Visa Card Number Expiration Date Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenRetake Code (HIDDEN) HiddenQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
